Vistra Corp. (VST)
NYSEUtilitiesUtilities - Independent Power ProducersSnapshot 2026-07-07
$155.73-0.95%
Close 2026-07-07 · 1-day change
Reading VST? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track VST free→NYSEUtilitiesUtilities - Independent Power ProducersSnapshot 2026-07-07
Reading VST? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track VST free→QuarterlyIQ Insights · VST
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 11 valuation methods, at three horizons. Current price $155.73. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A long-thesis check that carries the widest uncertainty of the three horizons.
Bottom 25% on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $156 VST trades at 20× p/e, below its 24× p/e peer median. Our $164 fair value sits above the price. We hold it with medium confidence: our number sits below the analyst range and quality doesn't explain valuation multiples in this sub-industry, so the peer comparison is a weak guide. Analysts target $187–$230. Note: our $164 fair value sits below the entire analyst range ($187–$230). Not investment advice.
$187.00 – $230.00 (median $208.00) · 7 analysts · as of 2026-06-24
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Only weak execution quality — not the full expensive x weak x turbulent stack. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
At today's price you pay about 61% over what the business is worth with no growth; closing that gap needs roughly 3.5 years of the forecast growth to come through. These describe the expectations embedded in the price, not a forecast of the move. Reverse-DCF base: $6.18/sh owner earnings.
Looks cheaper than most peers in the same business.
Cheaper than its own typical valuation.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $208.00 | — | — | Analyst | high |
| dcf fcfe | 12M | $100.11 | — | — | Analyst | high |
| dcf fcff | 12M | $75.45 | — | — | Analyst | high |
| graham number | 12M | $53.70 | — | — | TTM | high |
| Peer P/FCF | 12M | $254.83 | 77.4 | 3.29 | TTM | high |
| Peer P/E | 12M | $190.85 | 24.4 | 7.81 | TTM | high |
| Peer P/S | 12M | $174.74 | 3.1 | 56.88 | TTM | high |
| PEG | 12M | $389.97 | 49.9 | 7.81 | TTM | high |
| residual income | 12M | $38.34 | — | — | TTM | high |
| Own P/E history | 12M | $191.17 | 24.5 | 7.81 | TTM | high |
| triangulated | 12M | $188.29 | 24.4 | 7.71 | Triangulated | high |
| Peer P/E | 3Y | $343.89 | 24.4 | 14.07 | Analyst | medium |
| Peer P/S | 3Y | $283.35 | 3.1 | 92.23 | Analyst | medium |
| PEG | 3Y | $702.69 | 49.9 | 14.07 | Analyst | medium |
| Own P/E history | 3Y | $344.46 | 24.5 | 14.07 | Analyst | medium |
| Peer P/E | 5Y | $454.79 | 24.4 | 18.61 | Analyst | high |
| Peer P/S | 5Y | $374.73 | 3.1 | 121.98 | Analyst | high |
| PEG | 5Y | $929.31 | 49.9 | 18.61 | Analyst | high |
| Own P/E history | 5Y | $455.55 | 24.5 | 18.61 | Analyst | high |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.